Key result
Targeting the TLR4/MAPKs signaling pathway shows potential for inhibiting atherosclerosis.
Key points are not available for this paper at this time.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Janeesh Plakkal Ayyappan (2014) studied this question. Targeting the TLR4/MAPKs signaling pathway represents a potential therapeutic option for the inhibition of atherosclerosis.
Synapse has enriched 5 related papers. Consider them for comparative context: